QS-Rapamycin
53123-88-9
C51h79no13
610-965-5
Negotiable
Normal
>12 Months
Rapamycin
Rapamycin
>99%
Rapamycin
Rapamycin Powder
White Powder
White
Pharmaceutical Grade
>99%
Pharmaceutica
COA
HPLC
C51h79no13
914.17186
185c
1.182
973.017c
2.4
QS-Rapamycin
Negotiable
>99%
Xi`an
Product Description

Pharmaceutical Rapamycin Sirolimus Rapamycin




| Name | Rapamycin Powder |
| Product Name | Rapamycin |
| Appearance | White Powder |
| Assay | >99% |
| Application | Pharmaceutica |
| Melting Point | 185C |
| MF | C51H79NO13 |
| MV | 914.17186 |
Rapamycin, a triene macrolide antibiotic, possesses antifungal, anti-inflammatory, antitumor, and immunosuppressive effects. It effectively blocks T-cell activation and proliferation, inhibits the activation of p70 S6 kinase, and forms strong interactions with FK506 binding proteins. Additionally, rapamycin targets and suppresses the activity of mTOR (mammalian target of rapamycin), a protein that plays a key role in signaling pathways driving tumor growth. By binding to the receptor protein FKBP12, the resulting rapamycin/FKBP12 complex attaches to mTOR, disrupting its ability to interact with downstream target proteins and thereby inhibiting tumor-promoting signaling.





























